Reprogramming cell identity in the pituitary gland

A discovery by IRCM researchers could lead to new treatments for Cushing's disease

2012-10-17

(Press-News.org) A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming. This important discovery, published yesterday by the scientific journal Genes & Development, could eventually lead to new pharmacological targets for the treatment of Cushing's disease.

Dr. Drouin's team studies the pituitary gland, which is the master gland located at the base of the skull that secretes hormones to control all other glands of the endocrine system. Disruption of pituitary functions has dire consequences on growth, reproduction and metabolism.

Within the pituitary gland, each hormone is produced by cells of a different lineage. Unique cell identities are created by cell-specific genetic programs that are implemented during development. Appropriate cell programming is a critical process that needs to be harnessed in order to exploit the therapeutic benefits of stem cell research.

In their work, the IRCM researchers showed that the transcription factor Pax7 has pioneering abilities, meaning that it is able to open the tightly-packed chromatin structure of specific regions of the genome. This unmasking of a subset of the genome's regulatory sequences changes the genome's response to differentiation signals such that different cell types are generated.

"We reprogrammed the identity of pituitary cells by using the Pax7 gene in order to create two different types of cells," says Lionel Budry, former student in Dr. Drouin's laboratory and first author of the article. "This allowed us to show that the Tpit protein produces different cell lineages according to the presence or absence of Pax7, and its impact on chromatin organisation."

Cushing's disease is caused by small tumours of the pituitary gland that produce excessive amounts of hormones. For patients with this disease, the abnormal hormone production can lead to hypertension, obesity, diabetes and osteoporosis.

"For approximately 10% of patients suffering from Cushing's disease, we found that the disease-causing tumours contain cells that express the Pax7 protein," explains Dr. Drouin, Director of the Molecular Genetics research unit at the IRCM. "No effective pharmacological treatment currently exists for Cushing's disease. This discovery could ultimately lead to the development of such treatment, based on tumour growth inhibition by hormones, similarly to what is already done for other pituitary tumours like lactotrope adenomas."

### About the research project This research project was funded by the Canadian Institutes for Health Research (CIHR) and the Canadian Cancer Society Research Institute. Contributors from Jacques Drouin's laboratory also include Aurélio Balsalobre, Yves Gauthier, Konstantin Khetchoumian, Aurore L'Honoré and Sophie Vallette. In addition, IRCM scientists worked in collaboration with researchers from the Université de la Méditerranée and Hopital La Timone, Marseille in France and Utrecht University in the Netherlands.

For more information on this discovery, please refer to the article summary published online by Genes & Development: http://genesdev.cshlp.org/content/26/20/2299.abstract

About Dr. Jacques Drouin Jacques Drouin obtained his Doctor of Science in Physiology from the Université Laval. He is IRCM Research Professor and Director of the Molecular Genetics research unit. Dr. Drouin is a professor in the Department of Biochemistry at the Université de Montréal. He is also associate member of the Department of Medicine (Division of Experimental Medicine), adjunct professor of the Department of Anatomy and Cell Biology, and adjunct member of the Department of Biochemistry at McGill University. In addition, he is an elected member of the Academy of Sciences of the Royal Society of Canada. For more information, visit www.ircm.qc.ca/drouin.

About the Institut de recherches cliniques de Montréal (IRCM) Founded in 1967, the IRCM (www.ircm.qc.ca) is currently comprised of 37 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.

ELSE PRESS RELEASES FROM THIS DATE:

New diabetes screening guidelines released

2012-10-17

OTTAWA, ONTARIO, CANADA — Routine screening for type 2 diabetes in adults at low and moderate risk is not recommended, although it is recommended for people at high and very high risk of the disease, state new diabetes screening guidelines published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/content/184/15/1687.full. The guidelines suggest using a risk calculator and then screening based on the predicted risk of diabetes. "These new guidelines bring precision and convenience with web-based risk calculators and nonfasting A1C to diabetes screening," ...

Marriage, education can help improve well-being of adults abused as children

2012-10-17

Researchers investigating the long-term consequences of child abuse have identified some protective factors that can improve the health of victims during their adulthood. Men and women in their 30s who had been abused or neglected as children reported worse mental and physical health than their non-abused peers. But being married or having graduated from high school buffered the severity of their symptoms. The researchers also found that adults who experienced child abuse reported less happiness and self-esteem, more anger and other psychological damage, indicating ...

Fostering tomorrow's scientific breakthroughs: New American Chemical Society video

2012-10-17

WASHINGTON, Oct. 16, 2012 — A new episode in the American Chemical Society's (ACS') popular Prized Science video series features a virtuoso in teaching the next generation of scientists, who must discover tomorrow's life-saving medicines and new fuels and help solve other global challenges. The videos from the world's largest scientific society are available at www.acs.org/PrizedScience and by request on DVD. Titled Prized Science: How the Science Behind American Chemical Society Awards Impacts Your Life, the fourth episode of the 2012 series features the work of Diane ...

Physics explains how sickling cells make people sick

2012-10-17

PHILADELPHIA (October 16, 2012)— Researchers at Drexel University have identified the physical forces in red blood cells and blood vessels underlying the painful symptoms of sickle cell disease. Their experiment, the first to answer a scientific question about sickle cell disease using microfluidics engineering methods, may help future researchers better determine who is at greatest risk of harm from the disease. They report their findings in Cell Press's Biophysical Journal today. Capillary Blockage Conundrum Like many scientific questions, this discovery began with ...

New study sheds new light on the progression and invasiveness of ductal breast cancer

2012-10-17

Philadelphia, PA, October 16, 2012 – Ductal carcinoma in situ (DCIS) is considered a precursor lesion for invasive breast cancer if untreated, and is found in approximately 45% of patients with invasive ductal carcinoma (IDC). Patients with DCIS only (not accompanied by invasive disease) have a 5-year-survival of nearly 100%, compared to 89% for all stages of invasive breast cancer (24% for patients with distant metastasis). A new study has found that despite an enormous degree of intercellular heterogeneity in both DCIS and IDC, the evolution from noninvasive to invasive ...

Non-disclosure of geographic earnings can be a marker of tax avoidance

2012-10-17

Multinational corporations that choose not to disclose geographic earnings are more likely to engage in income-shifting activities, says a study from UofT's Rotman School. Toronto – Policy makers, lobby groups and citizens should take note—those who understand corporate tax avoidance behavior will be in a better position to deter it. A recent study by Prof. Ole-Kristian Hope, who holds the Deloitte Professorship of Accounting at the Rotman School of Management at the University of Toronto, along with Mark (Shuai) Ma and Wayne B. Thomas from the Michael F. Price College ...

Fruit fly's 'sweet tooth' short-lived: U of British Columbia research

2012-10-17

The humble fruit fly may have something to teach us about forgoing empty calories for more nutritional ones – especially when we're hungry. While the flies initially prefer food with a sweet flavour, they quickly learn to opt for less sweet food sources that offer more calories and nutritional value, according to new research by University of British Columbia zoologists. The findings, published this week in the Journal of Neuroscience, are the first to measure the shift in food preference over time, and the first to find that flies opt for nutritious food more quickly ...

Patient-reported outcomes essential to comparative effectiveness research

2012-10-17

Chapel Hill, NC – Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group. In an early release article published this week online in the Journal of Clinical Oncology, a research group led by Ethan Basch, MD, Director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, recommends that patient-reported symptoms and health-related quality of life measures should be assessed in comparative effectiveness ...

Attack! Silent watchmen charge to defend the nervous system

2012-10-17

In many pathologies of the nervous system, there is a common event - cells called microglia are activated from surveillant watchmen into fighters. Microglia are the immune cells of the nervous system, ingesting and destroying pathogens and damaged nerve cells. Until now little was known about the molecular mechanisms of microglia activation despite this being a critical process in the body. Now new research from the Montreal Neurological Institute and Hospital – The Neuro - at McGill University provides the first evidence that mechanisms regulated by the Runx1 gene control ...

Nursing workloads multiply likelihood of death among black patients over white patients

2012-10-17

Older black patients are three times more likely than older white patients to suffer poorer outcomes after surgery, including death, when cared for by nurses with higher workloads, reports research from the University of Pennsylvania School of Nursing. The large-scale study showed higher nurse workloads negatively affected older surgical patients generally and that the rate was more significant in older black individuals. When the patient-to-nurse ratio increased above 5:1, the odds of patient death increased by 3 percent per additional patient among whites and by 10 percent ...

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

Reprogramming cell identity in the pituitary gland

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: